1 |
司盼, 裴璐璐, 方慧, 等. 非致残性缺血性脑血管病生物标记物研究进展 [J]. 中国卒中杂志, 2017, 12 (12): 1118-1122.
|
2 |
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2018, 49(3): 46-110.
|
3 |
Alnasser S, Huang W, Gore J, et al. Late consequences of acute coronary syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up [J]. Am J Med, 2015, 128(7): 766-775.
|
4 |
Patti G, Micieli G, Cimminiello C, et al. The role of Clopidogrel in 2020: a reappraisal [J]. Cardiovasc Ther, 2020, 2020: 8703627.
|
5 |
Li JH, Cao J, Fan L. Research progress on the clinical prevention and treatment of Clopidogrel resistance [J]. Chin J Geriatric Heart Brain Vessel Dis, 2015, 17(3): 1324-1326.
|
6 |
Klein MD, Lee CR, Stouffer GA. Clinical outcomes of CYP2C19 genotype-guided antiplaytelet therapy: existing evidence and futuredirections [J]. Pharmacogenomics, 2018, 19(13): 1039-1046.
|
7 |
Song BL, Wan M, Tang D, et al. Effects of CYP2C19 genetic polymorphisms on the pharmacokinetic and pharmacodynamic properties of Clopidogrel and its active metabolite in healthy Chinese subjects [J]. Clin Ther, 2018, 40(7): 1170-1178.
|
8 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682.
|
9 |
田苗, 范亚林, 王梅英, 等. PCI术后双联抗血小板治疗危险性急性上消化道出血的危险因素分析 [J]. 河北医药, 2020, 42(16): 2446-2450.
|
10 |
刘庆春. 血栓弹力图评价脑梗死患者应用阿司匹林、氯吡格雷及其两药联合的治疗作用 [J]. 血栓与止血学, 2020, 26 (1): 20-22.
|
11 |
Liu LP, David W, Lawrence W, et al. Stroke and stroke care in China: huge burden, significant workload, and a national priority [J]. Stroke, 2011, 42(12): 3651-3654.
|
12 |
Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes [J]. Circulation, 2015, 13(1): 40-46.
|
13 |
Shim EJ, Ryu CW, Park S, et al. Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis [J]. J Neurointerventional Surg, 2018, 10(10): 942-948.
|
14 |
Zhang QH, Wang C, Zheng MY, et al. Aspirin plus Clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis [J]. Cerebrovasc Dis, 2015, 39(1): 13-22.
|
15 |
Sim SC, Risinger C, Dahl ML, et al. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants [J]. Clin Pharmacol Ther, 2006, 79(1): 103-113.
|
16 |
Arwa MA, Lim SC, Mohamed ND, et al. The effect of CYP2C19 genetic polymorphism and mon genetic factors on Clopidogrel platelets inhibition in East Asian coro nary artery disease patients [J]. Thrombosis Res, 2017, 15(6): 22-24.
|
17 |
Chen JQ, Zhang Y, Hu BB, et al. Effect of CYP2C19 gene polymorphism on the curative effect of Clopidogrel in the treatment of acute cerebral infarction [J]. China Modern Doctor, 2017, 11(23): 6-9.
|
18 |
Fu H, Hu P, Ma C, et al. Association of Clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients. An observational study [J]. Medicine, 2020, 99: e19472.
|
19 |
肖飞燕, 张伟, 周宏灏, 等. 影响氯吡格雷疗效的基因多态性研究现状 [J]. 中国现代应用药学, 2016, 33(3): 375-380.
|
20 |
董露露, 凌静, 胡楠, 等. CYP2C19基因多态性与脑梗死患者氯吡格雷反应性的关系 [J]. 淮海医药, 2022, 40(1): 13-16.
|
21 |
刘亚巍, 赵小朗, 姚璞, 等. ABCB1、CYP2C19、CES1 基因多态性与缺血性脑卒中患者氯吡格雷抵抗及疗效的关系 [J]. 中国神经免疫学和神经病学杂志, 2021, 28(2): 146-151.
|
22 |
杨建业, 秦磊磊, 李飞龙, 等. 血栓弹力图临床应用的研究进展 [J]. 重庆医学, 2020, 49(1): 149-152.
|
23 |
Yeung MC, Tomg SY, Tong PY, et al. Use of viscoelastic haemostatic assay in emergency and elective surgery [J]. Hong Kong Med J, 2015, 21(1): 45‐51.
|
24 |
Di Sciascio G, Patti G, Pasceri V, et al. ARMYDA-4 RELOAD Investigators. Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic Clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of Myocardial Damage during Angioplasty) randomized trial [J]. Eur Heart J, 2010, 31(11): 1337-1343.
|
25 |
Wallentin L, James S, Storey RF, et al. PLATO Investigators. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus Clopidogrel for acute coronary syndromes: A genetic substudy of the PLATO trial [J]. Lancet, 2010, 376(9749): 1320-1328.
|
26 |
Wang YJ, Johnston C, Bath PM, et al. Clopidogrel with aspirin in high-risk patients with Acute Non-disabling Cerebrovascular Events Ⅱ (CHANCE-2): rationale and design of a multicentre randomised trial [J]. Stroke Vasc Neurol, 2021, 6(2): 280-285.
|